Trade Pfizer ^PFE

Pfizer (NYSE:PFE) Shares Up 1.3% - Time to Buy? - Markets Daily

Heartland Bank & Trust Co Invests $616,000 in Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Sold by California Public Employees Retirement System

Pfizer Stock Leads 3 AI Healthcare Names Worth Further Research

How Investors Are Reacting To BioNTech (BNTX) Expanded Global Patent Suits Targeting Its mRNA COVID-19 Vaccines

Immune correlates of risk for SARS-CoV-2 infection in children: a prospective, community-based cohort study

Overall survival according to timing of immune checkpoint inhibitors administration in patients with advanced cancer: results from a large single-centre cohort analysis

Pfizer confirms it had temporarily suspended its Premarin brand of vaginal cream in India

Crescent Bio derisks important drug trial | IFR

Boomers Swear by These High-Yield 5% and More Kings They Can Buy and Hold Forever

SteelPeak Wealth LLC Decreases Holdings in Pfizer Inc. $PFE

Illinois Municipal Retirement Fund Has $15.16 Million Stock Holdings in Pfizer Inc. $PFE

Pfizer Inc. $PFE Stake Decreased by SteelPeak Wealth LLC - Stock Observer

Pfizer Inc. $PFE Shares Sold by Financiere des Professionnels Fonds d investissement inc.

Bessemer Group Inc. Buys 5,028,603 Shares of Pfizer Inc. $PFE

Erste Group Bank Has Negative View of Pfizer FY2026 Earnings - Stock Observer

Gerald Baker Financial Group LLC Purchases New Holdings in Pfizer Inc. $PFE - Daily Political

Harel Insurance Investments & Financial Services Ltd. Acquires Shares of 24,000 Pfizer Inc. $PFE - Daily Political

Bessemer Group Inc. Acquires 5,028,603 Shares of Pfizer Inc. $PFE - Daily Political

Comparison of obecabtagene autoleucel versus an external control arm in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

BMJ Senior Editor: COVID vaccines more likely to put you in hospital than keep you out

Pfizer (NYSE:PFE) Stock Price Up 1.3% - Here's Why

Pfizer (NYSE:PFE) Trading Up 1.3% - What's Next? - Stock Observer

Best Dividend Stocks To Follow Now - July 16th - Stock Observer

Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech - Update | Morningstar

Pfizer Inc. $PFE Shares Purchased by Wealthfront Advisers LLC

Pfizer Inc. $PFE Shares Sold by Twin Capital Management Inc.

Pfizer Inc. $PFE Stock Holdings Boosted by Sanctuary Advisors LLC

D.A. Davidson & CO. Purchases 90,012 Shares of Pfizer Inc. $PFE

Pfizer says new anti-COVID pill is 'a game-changer' | Israel National News

Pfizer CEO backs out of EU COVID committee hearing

Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results

Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage

Clinician expertise and prompt engineering enhance cancer information extraction in electronic health records by small language models

Pfizer (NYSE:PFE) Shares Up 2.1% - Here's What Happened

Prediction: This Dividend King Could End The Year With a New All-Time High Stock Price

Stock Market Is Giving A Pristine Entry Point Into This 64-Year Dividend King

Pfizer (PFE) Announces FDA Approval of PADCEV plus Keytruda in MIBC

AM Best Affirms Credit Ratings of Blue Whale Re Ltd.

Is the Bearishness Around Pfizer and Gilead Sciences a Contrarian Opportunity?

Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer

Sanofi launches mRNA lawsuits on Moderna and Pfizer

Pfizer Inc. $PFE Shares Acquired by Sterling Investment Advisors Ltd. - Daily Political

Bleakley Financial Group LLC Buys 25,800 Shares of Pfizer Inc. $PFE - Daily Political

Pfizer vaccine generates strong immune response in children under 5

FDA report finds all-cause mortality higher among vaccinated

Pfizer says vaccine is 100% effective in protecting adolescents

Report: Ministry of Health contacted Pfizer regarding COVID pill

3 Stocks I Will Be Avoiding

The 10 Best Dividend Stocks for 2026 | Morningstar

Pfizer (PFE) Stock Looks Fully Priced After Its 21% Slump

This Healthcare Giant Still Checks Every Box for Long-Term Investors

Pfizer Vs. Amgen: Bet That Pfizer's Seagen Integration Leads to Long-Term Oncology Alpha Over Amgen

Here's What to Expect From Pfizer's Next Earnings Report

Pfizer Inc. $PFE Shares Sold by Calamos Advisors LLC

PFE: Oncology And Obesity Pipeline Will Drive Post Patent Cliff Repricing

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

Protect your portfolio from volatility with these high-dividend stocks, Jefferies says

Metastatic Castration-resistant Prostate Cancer Market Poised for Strong Growth by 2036, Due to the Launch of Drug Classes Such as Anti-B7-H3 ADC, PROTAC Protein Degrader, NTD AR Inhibitor, Radionuclide Therapy, and Several Others | DelveInsight

Pfizer Drops Patent Suit Over Alkem Copies of Inlyta Cancer Drug

Pfizer (NYSE:PFE) Given New $30.00 Price Target at BMO Capital Markets

Termination after employee's protected activity may not be unlawful retaliation

Pfizer (NYSE:PFE) Price Target Cut to $35.00 by Analysts at Guggenheim

Manning & Napier Advisors LLC Raises Stock Position in Pfizer Inc. $PFE - Markets Daily

BMO Capital Markets Issues Pessimistic Forecast for Pfizer (NYSE:PFE) Stock Price - Stock Observer

Pfizer Inc. $PFE Shares Purchased by CORDA Investment Management LLC.

Manning & Napier Advisors LLC Boosts Position in Pfizer Inc. $PFE - Stock Observer

Buy Pfizer; target of Rs 6000: ICICI Securities

Pfizer sued for patent infringement in Paxlovid development

Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasms

An anti-PMEL antibody−drug conjugate with a Gq/11 inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial

Pfizer Inc. $PFE Position Lifted by Fifth Third Bancorp

International Assets Investment Management LLC Has $4.35 Million Holdings in Pfizer Inc. $PFE - Stock Observer

Pfizer Inc. $PFE Shares Bought by Fifth Third Bancorp - Stock Observer

Iran apologized to Trump for unauthorized strikes by hardliners that helped quash ceasefire: reports | Watch News Videos Online

Pfizer (PFE) Wins FDA Approval For First Platinum Free Bladder Cancer Regimen

Pfizer Inc. $PFE Shares Sold by Torray Investment Partners LLC - Markets Daily

Pfizer Inc. $PFE Shares Bought by Beacon Harbor Wealth Advisors Inc.

FDA's PADCEV Keytruda Approval for All MIBC Patients Might Change The Case For Investing In Astellas Pharma (TSE:4503)

Iran devises new plan to assassinate Trump: report | Watch News Videos Online

Merck, Pfizer, Astellas Bladder Cancer Treatment Approved by FDA | Morningstar

Bank of America Lowers Pfizer (NYSE:PFE) Price Target to $26.00 - Zolmax

Bank of America Issues Pessimistic Forecast for Pfizer (NYSE:PFE) Stock Price

FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults With Muscle-Invasive Bladder Cancer (MIBC) | Morningstar

Growing concerns over NYC high-rise stability following Pfizer building incident

McDonald's or Pfizer: One Offers Real Growth, One Just Pays You to Wait

Jim Cramer on Pfizer: "I Can't Come Up With Where the Growth Is"

Kestra Advisory Services LLC Boosts Position in Pfizer Inc. $PFE

Pfizer Inc. $PFE Shares Bought by Elevated Capital Advisors LLC

First Horizon Corp Increases Stock Holdings in Pfizer Inc. $PFE

U.S. House committee investigates pharmaceutical giants for clinical trials at Chinese military hospitals - NaturalNews.com

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Trump Announces 25% Tariffs on Automobiles, Pharmaceuticals, and Semiconductors

Week Ahead: US And Canada Labour Markets Are In Focus, BoE Rate Decision

Stock price forecast: 4 S&P 500 Stocks for 2025

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Week ahead: Apple earnings land as Fed seen holding rates

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk